Dr. Maurie Markman on the Phase III AURELIA Trial for Platinum-Resistant Ovarian Cancer

Dr. Eric Pujade-Lauraine on the AURELIA Bevacizumab Trial for Platinum-Resistant Ovarian CancerПодробнее

Dr. Maurie Markman on Targets for the Treatment of Ovarian CancerПодробнее

AURELIA: Phase 3 trial of bevacizumab combined with chemotherapy for ovarian cancerПодробнее

Dr. Maurie Markman Developing Research Into Checkpoint Inhibitors in Ovarian CancerПодробнее

Dr. Markman on the Future of Treatment for Ovarian CancerПодробнее

AURELIA: Phase 3 trial of bevacizumab combined with chemotherapy for ovarian cancerПодробнее

Unmet clinical needs for platinum-resistant ovarian cancer patientsПодробнее

Dr. Markman on Endpoints in Clinical Trials for Ovarian CancerПодробнее

Dr. Markman on Immune Targeting in Ovarian CancerПодробнее

Dr. Maurie Markman on the PROFILE 1007 Crizotinib TrialПодробнее

Ovarian Cancer Maintenance TherapiesПодробнее

Dr. Maurie Markman on the Further Study of PD-1 Inhibitors in Ovarian CancerПодробнее

Case 4: Recurrent Ovarian Cancer, Platinum-Resistant, BRCA WTПодробнее

Dr. Markman on Precision Medicine in Ovarian CancerПодробнее

Bevacizumab in Platinum-Resistant Ovarian CancerПодробнее

Dr. Markman on Combination Treatments in Ovarian CancerПодробнее

Dr. Markman Discusses Treating Ovarian Cancer as Chronic DiseaseПодробнее

Dr. Markman on Important Factors of BSO in Ovarian CancerПодробнее

Diagnosis of Metastatic Platinum-Resistant Ovarian CancerПодробнее